Related Experiment Video
Updated: Feb 25, 2026

05:56
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
2.2K
ACUPUNCTURE AS AN ANTI-EMETIC IN MINOR GYNAECOLOGICAL SURGERY
1Graded Specialist, Dept of Anaesthesiology, CH AF, Bangalore - 560 007.
Medical Journal, Armed Forces India
|August 10, 2017
Summary
Acupuncture at point P6 significantly reduced postoperative nausea and vomiting in gynecological surgery patients. This study suggests acupuncture is a viable anti-emetic option warranting further investigation.
Area of Science:
- Anesthesiology
- Complementary Medicine
- Surgical Nursing
Background:
- Postoperative nausea and vomiting (PONV) are common complications after gynecological surgery.
- Current anti-emetic strategies have limitations and side effects.
- Exploring novel preventive measures for PONV is crucial.
Purpose of the Study:
- To evaluate the efficacy of acupuncture as an anti-emetic intervention.
- To assess the impact of acupuncture at point P6 on PONV incidence.
- To determine acupuncture's potential role in managing postoperative emesis.
Main Methods:
- A randomized controlled study involving 100 patients undergoing minor gynecological surgery.
- Study group (n=50) received acupuncture at point P6 pre-anesthesia.
- Control group (n=50) received no acupuncture; anesthesia was standardized.
Main Results:
- Acupuncture significantly reduced emetic episodes: 10% in the acupuncture group vs. 40% in the control group.
- Acupuncture at P6 demonstrated a strong anti-emetic effect.
- The incidence of nausea and vomiting was substantially lower with acupuncture.
Conclusions:
- Acupuncture at point P6 is effective in preventing postoperative nausea and vomiting.
- Acupuncture represents a promising non-pharmacological anti-emetic modality.
- Further research into acupuncture's anti-emetic applications is recommended.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
740
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
740
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
683
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
683
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
966
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
966

